secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kyverna Therapeutics, Inc. (KYTX)
CIK:        0001994702
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0000950170-24-131074
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kyverna CMO James Chung resigns; receives $220K severance and COBRA
-------------------------------------------------------------------

- CMO James Chung's employment terminated effective November 22, 2024.
- Severance of $220,000 (6 months base salary) plus COBRA premiums for up to 6 months.
- Stock options cease vesting as of Separation Date; release of claims signed.
- No replacement named; Company expresses best wishes in future endeavors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1994702/000095017024131074/0000950170-24-131074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1994702/000095017024131074/kytx-20241126.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-131074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer